1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
61 2 9428 6555
https://www.cochlear.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 4.000
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, Pres & Exec. Director | 4,05M | N/D | 1967 |
Mr. Stuart Sayers | Chief Financial Officer | 692,93k | N/D | N/D |
Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 1,68M | N/D | 1965 |
Mr. Richard Brook MBA | Pres of EMEA | 1,69M | N/D | N/D |
Mr. Anthony Bishop | Pres of Asia Pacific & Latin American Regions | 1,09M | N/D | N/D |
Mr. David Hackshall | Chief Information Officer | N/D | N/D | N/D |
Ms. Kristina Devon | VP of Investor Relations | N/D | N/D | N/D |
Ms. Jennifer Stevenson | VP of Corp. Communications & Brand | N/D | N/D | N/D |
Mr. Dean Phizacklea | Sr. VP of Global Strategic Marketing | N/D | N/D | N/D |
Ms. Jennifer Hornery | Sr. VP of Global People & Culture | N/D | N/D | N/D |
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
L'ISS Governance QualityScore di Cochlear Limited al 1 luglio 2022 è 1. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 4; diritti degli azionisti: 1; retribuzione: 1.